Clinical Trial Update: Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX® [Phase 3]

View source ↗

Summary

Phase 3 trial comparing LY01005 to ZOLADEX in breast cancer completed, reporting efficacy and safety results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• LY01005
• Zoladex (goserelin)

Snippet

Sponsor: Luye Pharma Group Ltd. | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED